Funding for this research was provided by:
Bundesministerium für Wirtschaft und Energie (01MT14001C)
H2020 Marie Skłodowska-Curie Actions (No. 752652)
Received: 2 April 2020
Accepted: 10 July 2020
First Online: 29 July 2020
Ethics approval and consent to participate
: The study was approved by the Ethical Committee of the Medical Faculty of the Friedrich-Alexander-Universität Erlangen-Nürnberg. Informed written consent was obtained from all affected individuals.
: Not Applicable.
: M.J.C. and C. L. are employees of Siemens Healthcare. J.E. reports honaria from Eisai. P.A.F reports grants from Novartis, Cepheid, and Biontech and personal fees from Novartis, Roche, Pfizer, Celgene, Daiichi-Sankyo, TEVA, Astra Zeneca, Merck Sharp & Dohme, Myelo Therapeutics, Macrogenics, Eisai and Puma. The other authors declare no competing financial interests.